NAGE
Niagen Bioscience, Inc. Common Stock
NAGE
NAGE
75 hedge funds and large institutions have $25.3M invested in Niagen Bioscience, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 21 increasing their positions, 25 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
75
Holders Change
-7
Holders Change %
-8.54%
% of All Funds
1.27%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
15
Increased
21
Reduced
25
Closed
19
Calls
$100K
Puts
$117K
Net Calls
-$17K
Net Calls Change
-$240K
Top Buyers
1 |
TCM
Tieton Capital Management
Yakima,
Washington
|
$3.82M |
2 |
Millennium Management
New York
|
$1.28M |
3 |
Renaissance Technologies
New York
|
$1.24M |
4 |
Citadel Advisors
Miami,
Florida
|
$623K |
5 |
E
Ergoteles
New York
|
$385K |